1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Skin Testing 1.2.3 Laboratory Testing 1.3 Market by Application 1.3.1 Global Tuberculosis Diagnostics and Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Tuberculosis Diagnostics and Treatment Market Perspective (2016-2027) 2.2 Tuberculosis Diagnostics and Treatment Growth Trends by Regions 2.2.1 Tuberculosis Diagnostics and Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Tuberculosis Diagnostics and Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Tuberculosis Diagnostics and Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Tuberculosis Diagnostics and Treatment Industry Dynamic 2.3.1 Tuberculosis Diagnostics and Treatment Market Trends 2.3.2 Tuberculosis Diagnostics and Treatment Market Drivers 2.3.3 Tuberculosis Diagnostics and Treatment Market Challenges 2.3.4 Tuberculosis Diagnostics and Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue 3.1.1 Global Top Tuberculosis Diagnostics and Treatment Players by Revenue (2016-2021) 3.1.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Tuberculosis Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Tuberculosis Diagnostics and Treatment Revenue 3.4 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio 3.4.1 Global Tuberculosis Diagnostics and Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostics and Treatment Revenue in 2020 3.5 Tuberculosis Diagnostics and Treatment Key Players Head office and Area Served 3.6 Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service 3.7 Date of Enter into Tuberculosis Diagnostics and Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Tuberculosis Diagnostics and Treatment Breakdown Data by Type 4.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Type (2016-2021) 4.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2022-2027) 5 Tuberculosis Diagnostics and Treatment Breakdown Data by Application 5.1 Global Tuberculosis Diagnostics and Treatment Historic Market Size by Application (2016-2021) 5.2 Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Tuberculosis Diagnostics and Treatment Market Size (2016-2027) 6.2 North America Tuberculosis Diagnostics and Treatment Market Size by Type 6.2.1 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) 6.2.2 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) 6.2.3 North America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027) 6.3 North America Tuberculosis Diagnostics and Treatment Market Size by Application 6.3.1 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) 6.3.2 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) 6.3.3 North America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027) 6.4 North America Tuberculosis Diagnostics and Treatment Market Size by Country 6.4.1 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) 6.4.2 North America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Tuberculosis Diagnostics and Treatment Market Size (2016-2027) 7.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type 7.2.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) 7.2.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) 7.2.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027) 7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Application 7.3.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) 7.3.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) 7.3.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027) 7.4 Europe Tuberculosis Diagnostics and Treatment Market Size by Country 7.4.1 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) 7.4.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size (2016-2027) 8.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type 8.2.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application 8.3.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region 8.4.1 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Tuberculosis Diagnostics and Treatment Market Size (2016-2027) 9.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type 9.2.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027) 9.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application 9.3.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027) 9.4 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country 9.4.1 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size (2016-2027) 10.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type 10.2.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application 10.3.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country 10.4.1 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Cepheid Inc 11.1.1 Cepheid Inc Company Details 11.1.2 Cepheid Inc Business Overview 11.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Introduction 11.1.4 Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.1.5 Cepheid Inc Recent Development 11.2 Becton Dickinson 11.2.1 Becton Dickinson Company Details 11.2.2 Becton Dickinson Business Overview 11.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Introduction 11.2.4 Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.2.5 Becton Dickinson Recent Development 11.3 Hain LifeSciences 11.3.1 Hain LifeSciences Company Details 11.3.2 Hain LifeSciences Business Overview 11.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Introduction 11.3.4 Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.3.5 Hain LifeSciences Recent Development 11.4 Abbott Laboratories 11.4.1 Abbott Laboratories Company Details 11.4.2 Abbott Laboratories Business Overview 11.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Introduction 11.4.4 Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.4.5 Abbott Laboratories Recent Development 11.5 Alere, Inc 11.5.1 Alere, Inc Company Details 11.5.2 Alere, Inc Business Overview 11.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Introduction 11.5.4 Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.5.5 Alere, Inc Recent Development 11.6 Roche AG 11.6.1 Roche AG Company Details 11.6.2 Roche AG Business Overview 11.6.3 Roche AG Tuberculosis Diagnostics and Treatment Introduction 11.6.4 Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.6.5 Roche AG Recent Development 11.7 Hologic Corporation 11.7.1 Hologic Corporation Company Details 11.7.2 Hologic Corporation Business Overview 11.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Introduction 11.7.4 Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.7.5 Hologic Corporation Recent Development 11.8 bioMerieux 11.8.1 bioMerieux Company Details 11.8.2 bioMerieux Business Overview 11.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Introduction 11.8.4 bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.8.5 bioMerieux Recent Development 11.9 Sanofi 11.9.1 Sanofi Company Details 11.9.2 Sanofi Business Overview 11.9.3 Sanofi Tuberculosis Diagnostics and Treatment Introduction 11.9.4 Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.9.5 Sanofi Recent Development 11.10 QIAGEN 11.10.1 QIAGEN Company Details 11.10.2 QIAGEN Business Overview 11.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Introduction 11.10.4 QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.10.5 QIAGEN Recent Development 11.11 Akonni Biosystems, Inc. 11.11.1 Akonni Biosystems, Inc. Company Details 11.11.2 Akonni Biosystems, Inc. Business Overview 11.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Introduction 11.11.4 Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.11.5 Akonni Biosystems, Inc. Recent Development 11.12 Epistem Holdings Plc 11.12.1 Epistem Holdings Plc Company Details 11.12.2 Epistem Holdings Plc Business Overview 11.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Introduction 11.12.4 Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.12.5 Epistem Holdings Plc Recent Development 11.13 Gen-Probe Inc. 11.13.1 Gen-Probe Inc. Company Details 11.13.2 Gen-Probe Inc. Business Overview 11.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Introduction 11.13.4 Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.13.5 Gen-Probe Inc. Recent Development 11.14 EIKEN Chemical 11.14.1 EIKEN Chemical Company Details 11.14.2 EIKEN Chemical Business Overview 11.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Introduction 11.14.4 EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.14.5 EIKEN Chemical Recent Development 11.15 Thermo Fisher Scientific, Inc 11.15.1 Thermo Fisher Scientific, Inc Company Details 11.15.2 Thermo Fisher Scientific, Inc Business Overview 11.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Introduction 11.15.4 Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) 11.15.5 Thermo Fisher Scientific, Inc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Skin Testing Table 3. Key Players of Laboratory Testing Table 4. Global Tuberculosis Diagnostics and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Tuberculosis Diagnostics and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Tuberculosis Diagnostics and Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2016-2021) Table 8. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2022-2027) Table 10. Tuberculosis Diagnostics and Treatment Market Trends Table 11. Tuberculosis Diagnostics and Treatment Market Drivers Table 12. Tuberculosis Diagnostics and Treatment Market Challenges Table 13. Tuberculosis Diagnostics and Treatment Market Restraints Table 14. Global Tuberculosis Diagnostics and Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Tuberculosis Diagnostics and Treatment Market Share by Players (2016-2021) Table 16. Global Top Tuberculosis Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2020) Table 17. Ranking of Global Top Tuberculosis Diagnostics and Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Tuberculosis Diagnostics and Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Tuberculosis Diagnostics and Treatment Product Solution and Service Table 21. Date of Enter into Tuberculosis Diagnostics and Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Tuberculosis Diagnostics and Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Tuberculosis Diagnostics and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. Cepheid Inc Company Details Table 62. Cepheid Inc Business Overview Table 63. Cepheid Inc Tuberculosis Diagnostics and Treatment Product Table 64. Cepheid Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 65. Cepheid Inc Recent Development Table 66. Becton Dickinson Company Details Table 67. Becton Dickinson Business Overview Table 68. Becton Dickinson Tuberculosis Diagnostics and Treatment Product Table 69. Becton Dickinson Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 70. Becton Dickinson Recent Development Table 71. Hain LifeSciences Company Details Table 72. Hain LifeSciences Business Overview Table 73. Hain LifeSciences Tuberculosis Diagnostics and Treatment Product Table 74. Hain LifeSciences Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 75. Hain LifeSciences Recent Development Table 76. Abbott Laboratories Company Details Table 77. Abbott Laboratories Business Overview Table 78. Abbott Laboratories Tuberculosis Diagnostics and Treatment Product Table 79. Abbott Laboratories Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 80. Abbott Laboratories Recent Development Table 81. Alere, Inc Company Details Table 82. Alere, Inc Business Overview Table 83. Alere, Inc Tuberculosis Diagnostics and Treatment Product Table 84. Alere, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 85. Alere, Inc Recent Development Table 86. Roche AG Company Details Table 87. Roche AG Business Overview Table 88. Roche AG Tuberculosis Diagnostics and Treatment Product Table 89. Roche AG Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 90. Roche AG Recent Development Table 91. Hologic Corporation Company Details Table 92. Hologic Corporation Business Overview Table 93. Hologic Corporation Tuberculosis Diagnostics and Treatment Product Table 94. Hologic Corporation Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 95. Hologic Corporation Recent Development Table 96. bioMerieux Company Details Table 97. bioMerieux Business Overview Table 98. bioMerieux Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 99. bioMerieux Recent Development Table 100. Sanofi Company Details Table 101. Sanofi Business Overview Table 102. Sanofi Tuberculosis Diagnostics and Treatment Product Table 103. Sanofi Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 104. Sanofi Recent Development Table 105. QIAGEN Company Details Table 106. QIAGEN Business Overview Table 107. QIAGEN Tuberculosis Diagnostics and Treatment Product Table 108. QIAGEN Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 109. QIAGEN Recent Development Table 110. Akonni Biosystems, Inc. Company Details Table 111. Akonni Biosystems, Inc. Business Overview Table 112. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product Table 113. Akonni Biosystems, Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 114. Akonni Biosystems, Inc. Recent Development Table 115. Epistem Holdings Plc Company Details Table 116. Epistem Holdings Plc Business Overview Table 117. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product Table 118. Epistem Holdings Plc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 119. Epistem Holdings Plc Recent Development Table 120. Gen-Probe Inc. Company Details Table 121. Gen-Probe Inc. Business Overview Table 122. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product Table 123. Gen-Probe Inc. Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 124. Gen-Probe Inc. Recent Development Table 125. EIKEN Chemical Company Details Table 126. EIKEN Chemical Business Overview Table 127. EIKEN Chemical Tuberculosis Diagnostics and Treatment Product Table 128. EIKEN Chemical Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 129. EIKEN Chemical Recent Development Table 130. Thermo Fisher Scientific, Inc Company Details Table 131. Thermo Fisher Scientific, Inc Business Overview Table 132. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product Table 133. Thermo Fisher Scientific, Inc Revenue in Tuberculosis Diagnostics and Treatment Business (2016-2021) & (US$ Million) Table 134. Thermo Fisher Scientific, Inc Recent Development Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Global Tuberculosis Diagnostics and Treatment Market Share by Type: 2020 VS 2027 Figure 2. Skin Testing Features Figure 3. Laboratory Testing Features Figure 4. Global Tuberculosis Diagnostics and Treatment Market Share by Application: 2020 VS 2027 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Other Case Studies Figure 8. Tuberculosis Diagnostics and Treatment Report Years Considered Figure 9. Global Tuberculosis Diagnostics and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Tuberculosis Diagnostics and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Tuberculosis Diagnostics and Treatment Market Share by Regions: 2020 VS 2027 Figure 12. Global Tuberculosis Diagnostics and Treatment Market Share by Regions (2022-2027) Figure 13. Global Tuberculosis Diagnostics and Treatment Market Share by Players in 2020 Figure 14. Global Top Tuberculosis Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostics and Treatment as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostics and Treatment Revenue in 2020 Figure 16. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2016-2021) Figure 17. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Type (2022-2027) Figure 18. North America Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027) Figure 20. North America Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027) Figure 21. North America Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027) Figure 22. United States Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027) Figure 26. Europe Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027) Figure 27. Europe Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027) Figure 28. Germany Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027) Figure 36. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027) Figure 37. Asia-Pacific Tuberculosis Diagnostics and Treatment Market Share by Region (2016-2027) Figure 38. China Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027) Figure 46. Latin America Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027) Figure 47. Latin America Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027) Figure 48. Mexico Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Type (2016-2027) Figure 52. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Application (2016-2027) Figure 53. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Share by Country (2016-2027) Figure 54. Turkey Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Tuberculosis Diagnostics and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Cepheid Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 58. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 59. Hain LifeSciences Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 60. Abbott Laboratories Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 61. Alere, Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 62. Roche AG Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 63. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 64. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 65. Sanofi Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 66. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 67. Akonni Biosystems, Inc. Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 68. Epistem Holdings Plc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 69. Gen-Probe Inc. Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 70. EIKEN Chemical Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 71. Thermo Fisher Scientific, Inc Revenue Growth Rate in Tuberculosis Diagnostics and Treatment Business (2016-2021) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

Cepheid Inc Becton Dickinson Hain LifeSciences Abbott Laboratories Alere, Inc Roche AG Hologic Corporation bioMerieux Sanofi QIAGEN Akonni Biosystems, Inc. Epistem Holdings Plc Gen-Probe Inc. EIKEN Chemical Thermo Fisher Scientific, Inc